These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1729188)

  • 21. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.
    Tanghe A; Denis O; Lambrecht B; Motte V; van den Berg T; Huygen K
    Infect Immun; 2000 Jul; 68(7):3854-60. PubMed ID: 10858194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein.
    Kaufmann SH; Väth U; Thole JE; Van Embden JD; Emmrich F
    Eur J Immunol; 1987 Mar; 17(3):351-7. PubMed ID: 3106059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gammadelta T cells in immunity induced by Mycobacterium bovis bacillus Calmette-Guérin vaccination.
    Lee J; Choi K; Olin MR; Cho SN; Molitor TW
    Infect Immun; 2004 Mar; 72(3):1504-11. PubMed ID: 14977956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
    Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
    J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms involved in protective immune response generated by secretory proteins of Mycobacterium habana against experimental tuberculosis.
    Divya Jyothi M; Garg SK; Singh NB
    Scand J Immunol; 2000 May; 51(5):502-10. PubMed ID: 10792843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection.
    Denis O; Tanghe A; Palfliet K; Jurion F; van den Berg TP; Vanonckelen A; Ooms J; Saman E; Ulmer JB; Content J; Huygen K
    Infect Immun; 1998 Apr; 66(4):1527-33. PubMed ID: 9529077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.
    Derrick SC; Evering TH; Sambandamurthy VK; Jalapathy KV; Hsu T; Chen B; Chen M; Russell RG; Junqueira-Kipnis AP; Orme IM; Porcelli SA; Jacobs WR; Morris SL
    Immunology; 2007 Feb; 120(2):192-206. PubMed ID: 17076705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
    Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
    Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.
    Hoft DF; Kemp EB; Marinaro M; Cruz O; Kiyono H; McGhee JR; Belisle JT; Milligan TW; Miller JP; Belshe RB
    J Lab Clin Med; 1999 Sep; 134(3):244-52. PubMed ID: 10482309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Mycobacterial Ribosomal Proteins as Targets for CD4
    Kennedy SC; Johnson AJ; Bharrhan S; Lindestam Arlehamn CS; Xu J; Garforth SJ; Chan J; Jacobs WR; Sette A; Almo SC; Porcelli SA
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891545
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.
    Martin E; Kamath AT; Triccas JA; Britton WJ
    Infect Immun; 2000 Jun; 68(6):3090-6. PubMed ID: 10816448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.
    Vuola JM; Ristola MA; Cole B; Järviluoma A; Tvaroha S; Rönkkö T; Rautio O; Arbeit RD; von Reyn CF
    AIDS; 2003 Nov; 17(16):2351-5. PubMed ID: 14571187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.
    Derrick SC; Yang AL; Morris SL
    Infect Immun; 2005 Nov; 73(11):7727-35. PubMed ID: 16239577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice.
    Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H
    Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis.
    Buddle BM; Wards BJ; Aldwell FE; Collins DM; de Lisle GW
    Vaccine; 2002 Jan; 20(7-8):1126-33. PubMed ID: 11803073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.